What makes Bluesky different: it’s open source, so anyone can contribute to building the experience they want. And even if you build a whole new app, the protocol means you can migrate with your data, identity, and relationships intact.

Great #BBB Model to study malaria! Congrats Maria and Team!

Primary paper: www.cell.com/cell-reports...

🎓🇩🇪 Over 500 LMU students will get the Germany Scholarship in 2025 – a record! 💡 It provides €300/month, funded half by the government, half by private sponsors. Supporting talent and social engagement, no matter their background. #LMU #Scholarship #Education 👉 Read more: www.lmu.de/en/newsroom/....

'Stem Cells in Neuroscience' is returning to Tübingen, Germany. SAVE THE DATE: February 25-27, 2026. More info: stemcelltuebingen.com Please share #stemcelltuebingen2026 @dzne.science @hih-tuebingen.bsky.social @unituebingen.bsky.social @tueneurocampus.bsky.social

The #ClustersOfExcellence have been selected: today, the Excellence Commission approved 70 projects for funding. 45 clusters will continue and 25 will be newly established. Funding starts on 1 Jan 2026 for 7 years, with €539 million per year. The full list: www.dfg.de/resource/blo... 1/3

🎉 Major achievement for #LMU in the Excellence Strategy: All seven proposed Clusters of Excellence have successfully passed the review process and will be funded for seven years as of 2026. An outstanding result! 🎉 #ExcellenceCluster #LMUMunich #research Read more here: www.lmu.de/en/newsroom/...

…and our research cluster @synergy-munich.bsky.social is one of the funded ones! Big congratulations to all involved!

Important engagement by our Master student Stella:

Europe’s choice is clear. To put science at the heart of its economy. To become the home of scientific freedom and collaboration. And to welcome talent from all over the world. I’m glad to present the first elements of our Choose Europe Initiative. → europa.eu/!TTbWbJ

Excited to be at #Tau2025 in London! I really enjoy the great and inspiring discussions with all the fellow Tau enthusiasts! 🔬👩‍🔬

Great to be at #Tau2025 in London, where @angelikadannert.bsky.social from the lab presents our human #iPSC model of Tauopathies in a packed poster session

Great starter pack for Tau aficionados! Thanks Melissa

🚀 New study reveals how four different anti-amyloid drugs interact with amyloid beta protein. They found that lecanemab performed best in binding to small oligomeric forms of the amyloid protein, suggesting a working model for treating people in the earlier stages of Alzheimer’s (1/4)

Congratulations to Dr. Jean Paul Chadarevian and the entire @blurtonjoneslab.bsky.social team for this beautiful piece of work: Harnessing human iPSC-microglia for CNS-wide delivery of disease modifying proteins." 👍👍👍 www.sciencedirect.com/science/arti...

Losing sleep over #iPSC transgene silencing after differentiation? Same here — too many times😭 So we built a PiggyBac construct that resists silencing. Expression stays ON, even after differentiation. Our #preprint is out👇 🔗 www.biorxiv.org/content/10.1... Supported by @cziscience.bsky.social

It has taken decades to get to this point, but stem cells for Parkinson's disease showing promise in 2 clinical trials nature.com/articles/d41... nature.com/articles/s41... nature.com/articles/s41...

We are excited to announce Prof Malin Parmar, Ph.D. as our next webinar speaker! Title: Developing a Stem Cell Based Therapy for #Parkinsons Disease April 16 2025 9-10am (ET) 3-4pm (CET) Host: Henrietta Nielsen, Ph.D. Register: bit.ly/4jmX0d3

Welcome @ismnd.bsky.social to #Bluesky!

The telling is not only that scientists are avoiding trips to the 🇺🇸 It is the fact that most interviewed for this piece asked to remain anonymous with (very real) fear of retaliation. by @klangin.bsky.social www.science.org/content/arti...

If you are at #ADPD2025 in Vienna, please join us now in hall F1 to get an update about our human 3D #iPSC model of #Alzheimer disease!

Washington University-led research shows a small group of participants in an Alzheimer’s study experienced a significant delay in the onset of symptoms.

Great talks and discussions at the 🧠 #SCMND meeting in Edinburgh this week, where @julien-klimmt.bsky.social from our lab presented our #ipsc 3D brain tissue model for #Alzheimer’s diseases to a full audience

Great work, congrats Nico and team! 

Many thanks to @afi-ev.bsky.social‬ and their generous donors for supporting our work!!! Vielen Dank an AFI und ihre großzügigen Spender für die Unterstützung unserer Arbeit!!!

Open #Postdoc position @isd-research.bsky.social @lmumuenchen.bsky.social to develop an #iPSC-derived #BBB model. Fully funded and embedded in our international Foundation Leducq Network of Excellence www.brenda-leducq.de Experience in vascular biology or related field required. Please RP and apply

Did you know?🧐 🗺️The campuses Grosshadern and Martinsried together form a hotspot of life science research. Located at the♥️, @genecenter-lmu.bsky.social is part of a vibrant research community @lmumuenchen.bsky.social @lmu-klinikum.bsky.social @mpibiochem.bsky.social @bmc-lmu.bsky.social

Great lineup of speakers at #SCMND2025 and our own ECR @julien-klimmt.bsky.social#SCMND2025is one of them 😀 looking forward!

'We at Nature denounce this assault on science. And we encourage the global research community, wherever they can, to voice their opposition' doi.org/10.1038/d415... @nature.com

We did it and now it is published: A highly Lewy-fold selective and quantitative Synuclein Aggregate Amplification Assay (SAA). Huge thanks to the amazing teams at MODAG GmbH, LMU Munich, and Bologna University! rdcu.be/eaISM

👋 Meet our PhD and Postdoc Representatives 💭 The voice of our PhD students and Postdocs. A point of contact for feedback, questions, criticism, and improvements. And they organize extracurricular activities! Meet @angelikadannert.bsky.social, Clara, Lis and Nathalie. 🔗 Read more: lnkd.in/dKtzshqr

Save the date for the GSCN #Conference on #stemcell #research and #translation in #Munich at @www.helmholtz-munich.de from 15 - 17 Oct 2025. Registration is open gscn-conferences.org/gscn-confere...

A man was destined for early Alzheimer’s — these genes might explain his escape https://www.nature.com/articles/d41586-025-00398-4 (Edited 8:18 via @skeetsapp.com)

📣 Deadline coming up soon! Don't forget to register for the INTERACT MUNICH 2025 conference! 📅 3 - 4 April 2025 📍 Biomedical Center (BMC), LMU 💬 Young life scientists 📝 Abstract deadline: 24.02.2025 ➡️ lnkd.in/eKcwZJwV #interact #munich #interact2025 #conference #PhD #Master #Postdoc

Big congrats to the winners, including Marvin Reich, PhD student co-supervised by our lab in a nice collab with @haasslab.bsky.social

🚀 Record year for LMU spin-offs! 🚀 230 million euros in investments for startups from LMU Munich – from quantum computing to cancer therapies. A strong signal for research & innovation! 💡 You can read about the areas from which LMU's successful spin-offs originate here: www.lmu.de/en/newsroom/...

England's NHS approves a groundbreaking gene therapy for sickle cell disease, offering new hope to thousands. Known as Exa-cel or Casgevy and developed by CRISPR Therapeutics and Vertex Pharmaceuticals www.theguardian.com/society/2025... #Healthcare #Innovation #SickleCellDisease #GeneTherapy 🧬

What is Europe PMC? 🤷‍♀️ A platform that connects you to global life science publications and preprints from trusted sources. Developed by @ebi.embl.org it’s your gateway to open science and enhanced research visibility. Discover your next research tool: www.youtube.com/watch?v=2jyY...

Cool stuff: iPSC derived patches of heart cells to treat heart failure

🌟 <interact> 2025 Registration Now Open! 🌟 Prepare to meet our fantastic keynote speakers while enjoying inspiring networking with the participants 🧬✨ Explore and celebrate the impact of our research on the world around us alongside like-minded scientists. Let the <interact>ion begin!!

🫀A research team led by Martin Dichgans explored how HDAC9 influences vascular inflammation, discovering its role in regulating the NLRP3 inflammasome and creating a targeted anti-inflammatory treatment for treating atherosclerosis. 🔗 synergy-munich.de/news-events/...

A study led by ISD researchers suggests a key mechanistic link between Aβ and tau accumulation in Alzheimer’s disease, showing that Aβ induces neuronal hyperconnectivity, thereby promoting the spread of tau pathology across interconnected brain regions. 👍 www.science.org/doi/10.1126/...

www.cell.com/immunity/ful... - 👉ISD investigators now defined a mechanism whereby HDAC9 regulates activation of the NLRP3 inflammasome and developed a targeted anti-inflammatory approach for treating atherosclerosis. #HDAC9 #cell #immunity

Full-time position is available in the Laboratory of Associate Professor Agnieszka Wlodarczyk at the University of Southern Denmark in Neuroimmunology and Cell Therapy with bioinformatic expertise. Closing date: 25th February www.dementiaresearcher.nihr.ac.uk/job/postdoc-...

Many thanks @afi-ev.bsky.social for featuring and supporting our work on #microglia in #Alzheimer disease!

Great event in Munich!

AFI wishes all researchers a successful new year! We look forward to supporting you with your #dementia research: New applications for Travel Grants, Publication Grants and International Training Grants can now be submitted. (Open for phd candidates and post docs working at german public institutes)

One more day to apply for these neurodegeneration professorships!

🚨 Respurce alert: Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions